0.00Open0.00Pre Close0 Volume0 Open Interest11.00Strike Price0.00Turnover138.04%IV-30.49%PremiumMay 16, 2025Expiry Date2.57Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8398Delta0.1218Gamma3.09Leverage Ratio-0.0212Theta-0.0024Rho-2.60Eff Leverage0.0036Vega
Niagen Bioscience Stock Discussion
Revolutionary NAD+ Treatment: New Niagen IV Delivers 75% Faster Results in Nationwide Clinical Network
this is $Niagen Bioscience (NAGE.US)$ now
Game-Changing Patent Win: Niagen Locks Down Exclusive Rights to Critical NR Technology
Benzinga· 2mins ago
ChromaDex Transforms to Niagen Bioscience as NAD+ Leader Reports Record $99.6M Revenue
No comment yet